Company
Headquarters: Athens, Greece
Employees: 1,291
CEO: Mr. Emmanouil Doulgerakis
€183.2 Million
EUR as of Sept. 1, 2021
US$217.6 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
IASO S.A. operates hospitals, and a recovery and rehabilitation center in Europe. The company offers obstetrics and gynecology services, including gynecological oncology, endoscopic surgery, and pediatric and juvenile gynecology services, as well as delivery and operating rooms. It also provides diagnostics and therapeutics services comprising neonatal audiology; endocrinology, diabetes, and osteoporosis; and medical imaging, fetal medicine-gynecological ultrasounds, recurrent spontaneous abortions, neonatal cardiology, central laboratories, radiation oncology, breast center, cytology, urodynamics, medical oncology, surgical pathology, neonatal pediatrics, thyroid surgery department, and nuclear medicines, as well as plastic, reconstructive, and cosmetic surgery/laser services. In addition, the company offers outpatient department services, such as angiology, autoimmune rheumatic diseases and pregnancy, cardiology, check-up, colposcopy unit, dermatology, E.N.T, headache, hematology, nutritional support and dietetics, pediatric and adolescent gynecology, and male genito-urethral plastic surgery unit services, as well as endocrinology, diabetes, and osteoporosis services. Further, it operates intensive care, neonatal intensive care, and assisted reproduction units. IASO S.A. was founded in 1996 and is based in Athens, Greece. IASO S.A. is a subsidiary of Ocm Luxembourg Healthcare Greece S.à R.L.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
IASO SA has the following listings and related stock indices.
Stock: ASE: IASO wb_incandescent